• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: C.R. BARD, INC. (COVINGTON) -1018233 BARD® INLAY OPTIMA® URETERAL STENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

C.R. BARD, INC. (COVINGTON) -1018233 BARD® INLAY OPTIMA® URETERAL STENT Back to Search Results
Catalog Number 788624
Device Problems Break (1069); Material Split, Cut or Torn (4008)
Patient Problems No Patient Involvement (2645); No Known Impact Or Consequence To Patient (2692)
Event Date 11/28/2018
Event Type  malfunction  
Manufacturer Narrative
The investigation is still in progress.Once the investigation is complete a supplemental report will be filed.
 
Event Description
It was reported that the user found tear on the stent tip during preparation.
 
Event Description
It was reported that the user found tear on the stent tip during preparation.
 
Manufacturer Narrative
The reported issue was confirmed.The device was returned for evaluation.Visual inspection found a tear on the end of the stent.How and when the problem occurred could not be determined.The device history record was reviewed and found nothing that could have caused or contributed to the reported event.The instructions for use were found adequate and state the following: ¿method for use 1.(1) do not forcibly insert or remove the stent.It may injured patient or/and damage this product.(2) avoid improper handling of stent such as bending, kinking, tearing and etc.(3) avoid contact with sharp edges as this may cause damage to the stent.If grasping device is used, the stent should be removed from ureter first.Tearing of the stent can be caused by sharp instrument.(4) determine the proper stent length for the patient.Selection of too short a stent may result in migration.(5) in the event of stent migration , cystoscopy or ureteroscopy should be used to return the stent to the original position or removed it from the patient.(6) care should be exercise d when removing the stent to eliminate tearing or fragmentation.".
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
BARD® INLAY OPTIMA® URETERAL STENT
Type of Device
URETERAL STENT
Manufacturer (Section D)
C.R. BARD, INC. (COVINGTON) -1018233
8195 industrial blvd
covington GA 30014
MDR Report Key8200494
MDR Text Key131532795
Report Number1018233-2018-06205
Device Sequence Number1
Product Code FAD
Combination Product (y/n)N
PMA/PMN Number
K043193
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type distributor,other
Type of Report Initial,Followup
Report Date 03/06/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date08/01/2021
Device Catalogue Number788624
Device Lot NumberMYCVTE12
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer12/21/2018
Initial Date Manufacturer Received 12/04/2018
Initial Date FDA Received12/27/2018
Supplement Dates Manufacturer Received02/18/2019
Supplement Dates FDA Received03/06/2019
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
-
-